X-linked intellectual disability can be diagnosed in about 10–12% of intellectually disabled males. In the past, mutations affecting the PAK3 gene (p21 protein-activated kinase 3, MIM#300142) have been associated with a non-syndromic form of X-linked intellectual disability, which has to date been identified in a limited number of families. Since this neurodevelopmental disorder mostly afflicts males, descriptions of symptomatic female carriers are quite rare. We describe a female patient with neurodevelopmental delay and a novel PAK3 variant. Interestingly, she manifests craniofacial anomalies, including microcephaly, representing the second reported microcephalic female but the first for whom a detailed clinical description is available. She also displays other uncommon clinical findings, which we illustrate. Moreover, a comprehensive clinical and molecular review of all to date published patients has been made. This study contributes to further delineate the PAK3-related phenotype, which can be considered a non-syndromic X-linked intellectual disability, with seemingly recurrent craniofacial abnormalities.

Clinical and molecular aspects of the neurodevelopmental disorder associated with PAK3 perturbation / Pascolini, G.; Gaudioso, F.; Passarelli, C.; Novelli, A.; Di Giosaffatte, N.; Majore, S.; Grammatico, P.. - In: JOURNAL OF MOLECULAR NEUROSCIENCE. - ISSN 0895-8696. - 71:12(2021), pp. 2474-2481. [10.1007/s12031-021-01868-w]

Clinical and molecular aspects of the neurodevelopmental disorder associated with PAK3 perturbation

Gaudioso F.;Di Giosaffatte N.;Majore S.;Grammatico P.
Ultimo
2021

Abstract

X-linked intellectual disability can be diagnosed in about 10–12% of intellectually disabled males. In the past, mutations affecting the PAK3 gene (p21 protein-activated kinase 3, MIM#300142) have been associated with a non-syndromic form of X-linked intellectual disability, which has to date been identified in a limited number of families. Since this neurodevelopmental disorder mostly afflicts males, descriptions of symptomatic female carriers are quite rare. We describe a female patient with neurodevelopmental delay and a novel PAK3 variant. Interestingly, she manifests craniofacial anomalies, including microcephaly, representing the second reported microcephalic female but the first for whom a detailed clinical description is available. She also displays other uncommon clinical findings, which we illustrate. Moreover, a comprehensive clinical and molecular review of all to date published patients has been made. This study contributes to further delineate the PAK3-related phenotype, which can be considered a non-syndromic X-linked intellectual disability, with seemingly recurrent craniofacial abnormalities.
2021
craniofacial dysmorphisms; microcephaly; neurodevelopmental delay; PAK3
01 Pubblicazione su rivista::01i Case report
Clinical and molecular aspects of the neurodevelopmental disorder associated with PAK3 perturbation / Pascolini, G.; Gaudioso, F.; Passarelli, C.; Novelli, A.; Di Giosaffatte, N.; Majore, S.; Grammatico, P.. - In: JOURNAL OF MOLECULAR NEUROSCIENCE. - ISSN 0895-8696. - 71:12(2021), pp. 2474-2481. [10.1007/s12031-021-01868-w]
File allegati a questo prodotto
File Dimensione Formato  
Pascolini_Neurodevelopmental-disorder_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 6.57 MB
Formato Adobe PDF
6.57 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1627276
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact